InflaRx N.V.
IFRX • NASDAQ
InflaRx N.V. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Niels C. Riedemann, with a market cap of $65.9M.
Market Cap$65.9M
Employees66.0
CEONiels C. Riedemann
CountryGermany
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
IFR
InflaRx N.V. FAQ
Common questions about InflaRx N.V.
InflaRx N.V. is scheduled to report earnings for Q1 2026 on May 6, 2026. Analysts estimate revenue of $40.0K.
InflaRx N.V. has approximately 66 employees.